Diabetes Care Devices - Benelux | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in Benelux is projected to reach US$477.40m in 2024.
Revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 11.85%, which will lead to a market volume of US$835.70m by 2029.
In a global context, the majority of revenue will be generated the United States, with a figure of US$11.71bn in 2024.
The Benelux region is increasingly prioritizing innovative diabetes care devices, reflecting a growing emphasis on patient-centered healthcare solutions and technological advancements.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Benelux is witnessing considerable growth, fueled by factors such as the rising prevalence of diabetes, increased health awareness, advancements in technology, and the demand for more efficient self-monitoring solutions.

Customer preferences: In the Benelux region, consumers are prioritizing personalized diabetes care solutions that cater to their unique lifestyles and preferences. There is a growing inclination towards smart glucose monitoring devices that integrate seamlessly with mobile applications, allowing for real-time data tracking and analytics. Additionally, as awareness of diabetes management rises, individuals are increasingly favoring educational resources and community support networks that provide guidance on diet and exercise. This shift reflects a broader trend towards holistic health management that emphasizes both technology and lifestyle adaptation.

Trends in the market: In the Benelux region, the Diabetes Care Devices Market is increasingly centered on advanced digital solutions, with a notable rise in the adoption of continuous glucose monitoring (CGM) systems. These devices not only provide real-time glucose data but also connect with health apps for tailored insights, enhancing patient engagement. Moreover, there is a heightened focus on patient education and community involvement, as people seek resources that empower them to manage diabetes proactively. This trend signifies a shift towards integrated health solutions, presenting opportunities for manufacturers and healthcare providers to innovate and collaborate in delivering comprehensive diabetes management programs.

Local special circumstances: In the Benelux region, the Diabetes Care Devices Market is shaped by a combination of high healthcare standards and a strong emphasis on patient-centric care. The countries' robust healthcare infrastructure facilitates the integration of advanced digital solutions, enabling seamless data sharing between patients and providers. Cultural attitudes toward health encourage proactive diabetes management, while stringent regulatory frameworks ensure the safety and efficacy of devices. Additionally, the region's focus on sustainability drives demand for eco-friendly products, influencing manufacturers to innovate in both technology and materials.

Underlying macroeconomic factors: The Diabetes Care Devices Market in the Benelux region is significantly influenced by macroeconomic factors such as national economic stability, healthcare investment, and demographic trends. Strong economic performance in these countries supports increased healthcare spending, enabling healthcare providers to adopt advanced diabetes technologies. Additionally, favorable fiscal policies that encourage innovation and research in medical devices contribute to market growth. The rising prevalence of diabetes, coupled with an aging population, further drives demand for effective diabetes management solutions, making it essential for manufacturers to adapt to evolving patient needs and regulatory requirements.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.